Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE ISSUED OCTOBER 31, 2017: UTAH MEDICAL PRODUCTS, INC. INCREASES QUA - UTAH MEDICAL PRODUCTS INC | exh99_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 31, 2017
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
UTAH
|
87‑0342734
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number:
|
(801) 566‑1200
|
ITEM 8.01 OTHER EVENTS
On October 31, 2017, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.27 per share is payable on January 3, 2018 to shareholders of record at the close of business on December 15, 2017. A copy of the press release is attached hereto as Exhibit 99.1
ITEM 9.01 EXHIBITS
EXHIBIT INDEX
Index
|
|
Number
|
Description
|
99.1
|
Press release issued October 31, 2017: Utah Medical Products, Inc. Increases Quarterly Dividend
|
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
|
|
REGISTRANT
|
|
Date: 10/31/2017
|
By:/s/ Kevin L. Cornwell
|
Kevin L. Cornwell
|
|
CEO
|